MeSH tree: D03.633.400.686
Children born to mothers who used buprenorphine for opioid addiction during pregnancy do not have a greater risk of neurodevelopmental disorders, such as ADHD and autism, compared with children whose mothers took methadone, ...
Apr 15, 2026
0
6
New Monash University research has found that a free, interactive online tool can help people taking prescription opioids for pain to better understand their risks and adopt safer behaviors, more than doubling requests for ...
Apr 15, 2026
0
3
A new study exposes challenges in reversing opioid overdoses with naloxone when potent synthetic drugs like fentanyl and sufentanil are involved, according to a study published in the May 2026 issue of Anesthesiology. The ...
Apr 13, 2026
0
2
Medicaid insurance expansions between 2017 and 2023 sharply increased access to medication treatment for opioid use disorder in a period when fatal overdoses continued to climb, according to Rutgers Health researchers. Their ...
Apr 6, 2026
0
3
Methamphetamine—more commonly known as meth, crystal or ice—is a highly addictive, stimulant drug.
Apr 5, 2026
0
7
Proposals to ban or regulate kratom, a plant-based substance sold in gas stations, convenience stores and vape shops, are making headlines in local newspapers across the United States. But as lawmakers debate whether to regulate ...
Apr 3, 2026
0
8
In a clinical trial, a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder (OUD) during pregnancy led to higher rates of abstinence from illicit opioids ...
Mar 16, 2026
0
9
Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more likely to stay in treatment. Those on 17 to 24 milligrams averaged 190 days in care compared to ...
Mar 15, 2026
0
12
Opioids such as fentanyl are "indiscriminate killers" that can be misused by people from all walks of life. But where you live may be more influential than previously realized, according to researchers at Rutgers University.
Mar 9, 2026
0
9
State laws that ban insurance prior authorization for buprenorphine—a leading medication for opioid use disorder—may not help more patients stay in treatment for the recommended minimum of 180 days, Weill Cornell Medicine ...
Mar 6, 2026
0
6
